-
Chapter and Conference Paper
Mute Mate: An Advanced Lip-Reading Solution for Mute Participants in Virtual Conferences
Mute Mate is a lip-reading system that has been developed to aid mute individuals during online conferences. With the rising popularity of virtual and remote communication, the need to address the communicatio...
-
Article
Adenopathy in Multiple Myeloma: an Enigma Unravelled by FDG PET
-
Article
Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival
To analyze diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder (GBC) and to establish its possible impact on post-recurrence survival.
-
Article
Unmasking disseminated streptococcal infection: role of FDG PET/CT in diagnosis and assessing response to antibiotic treatment
-
Chapter and Conference Paper
Ensemble of Supervised Machine Learning Models for Cardiovascular Disease Prediction
Heart disorders, often referred to as cardiovascular diseases (CVDs), are the leading cause of mortality and a serious public health issue. The World Health Organization (WHO) estimated in 2016 that cardiovasc...
-
Chapter
PET/CT in Treatment Response Evaluation: Lung Cancer
18F-FDG PET/CT is recommended in the staging and treatment planning of lung cancer. There is no consensus on the optimal imaging technique for assessing response to treatment in lung cancer. However, FDG PET/CT ....
-
Chapter
PET/CT in the Assessment of Treatment Response in Hepatobiliary, Gall Bladder and Pancreatic Malignancies
18F-FDG PET is reported to be useful in assessing the efficacy of chemotherapy and other regional therapies in patients with hepatobiliary, gall bladder and pancreatic cancers. In patients with pancreatic cancer,...
-
Article
Gallbladder malakoplakia masquerading as malignant primary on 18F-FDG PET/CT
-
Chapter
PET CT in Non-Hodgkin Lymphoma
18F-FDG PET CT has changed the way we look at Non-Hodgkin Lymphoma (NHL). FDG PET CT is used for staging and response assessment in NHL. In this chapter we discuss the role of PET CT in assessing NHL.
-
Chapter
18F-FDG PET/CT in Treatment Response Evaluation: Gastroesophageal Cancer
Esophageal cancer has a high mortality rate, and surgery is the mainstay of treatment for the locoregional disease. However, approximately 20–30% of patients with locally advanced disease have distant metastat...
-
Article
Renal granulomas mimicking as malignant renal masses on F18 FDG PET/CT in a case of urothelial carcinoma
-
Article
Granulomatous hepatitis masquerading as metastases on FDG PET/CT
-
Article
Assessment of the impact of 2015 American Thyroid Association guidelines in management of differentiated thyroid cancer patients
The 2015 American Thyroid Association (ATA) guideline have suggested modifications in the risk stratification (RS) for differentiated thyroid cancer (DTC) patients, introduced the concept of dynamic risk strat...
-
Article
Correction to: The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II)
An Online First version of this article was made available online at http://springer.longhoe.net/journal/40291/onlineFirst/page/1 on 01 Nov 2018. An error was subsequently identified in the article, and the follo...
-
Article
The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II)
The present era of precision medicine sees “cancer” as a consequence of molecular derangements occurring at the commencement of the disease process, with morphological changes happening much later in the proce...
-
Article
The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I)
The present era of precision medicine sees ‘cancer’ as a consequence of molecular derangements occurring at the commencement of the disease process, with morphologic changes happening much later in the process...
-
Chapter
FDG PET/CT: Normal Variants, Artefacts and Pitfalls in Hepatobiliary and Pancreatic Malignancies
This review depicts the common variations in imaging appearances of biliary and pancreatic malignancies on FDG PET/CT. Pitfalls and artefacts arising due to treatment-related complications are also described.
-
Chapter
PET/CT in Pancreatic Malignancies
Pancreatic adenocarcinoma (PAC) accounts for about 85% of cases of pancreatic malignancies [1], and the term “pancreatic cancer” is sometimes used to refer only to that type. Imaging plays a central role in th...
-
Chapter
Hepatic Malignancies and FDG PET/CT
This chapter highlights the role of FDG PET/CT in primary hepatic malignancies and hepatic metastases.
-
Chapter
18F FDG PET/CT: Normal Variants, Artefacts and Pitfalls in Head and Neck Malignancy
This review depicts the unusual patterns of physiological and inflammatory FDG uptake in the head-neck region. Pitfalls and Artefacts arising due to treatment-related complications are also described.
